National Institutes of Health to Grant Exclusive License for Novel Opioid Synthesis Method

Summary

The National Institutes of Health is considering granting an exclusive license to Mallinckrodt Chemical, Inc. to practice a novel method of O-demethylation and N-deprotection of opioid compounds, which could improve the synthesis of synthetic medicinal opiates with high yields and without toxic reagents.